As we move full-speed ahead into fall, the new season brings with it a handful of headlines from our researchers at Children’s Hospital of Philadelphia. This week, we share the latest news about investigators who have been recognized for their research legacies and for their current cutting-edge work, from discoveries in the basic and clinical science of HIV/AIDS, to the development of learning health system-based training in outcomes research, to the design of innovative approaches to childhood cancer.
Tag Archive: HIV
This first of December, we’re recognizing World Aids Day by sharing the latest research from Children’s Hospital of Philadelphia investigators who partnered with the University of Pennsylvania, the University of Botswana, and the Botswana Ministry of Health through the Botswana-UPenn partnership, in order to address sub-Saharan Africa’s HIV/AIDS epidemic. Alongside their findings published last week, our news roundup also includes special congratulations to Diva De León-Crutchlow, MD, on a “sweet” new award from Congenital Hyperinsulinism International, and novel research findings from our investigators who study cardiology, genetics, and puberty.
Some of the neurological and psychiatric complications associated with HIV may be side effects of the medications that control the virus, and not caused by the virus itself, according to a new study from researchers at The Children’s Hospital of Philadelphia and the University of Pennsylvania.
Steven D. Douglas, MD received the Lectureship Award from the International Society for NeuroVirology (ISNV). The Lectureship Award recognizes a leading investigator for a systematic body of scientific research in neurovirology.
Last month, Dr. Farzan published a study in Nature that describes his team’s creation of a new molecule that prevents monkeys from being infected with simian/human immunodeficiency virus.
The Children’s Hospital of Philadelphia Research Institute’s own Philip R. Johnson, MD was consulted for a number of articles about an exciting new HIV vaccine study.
Exploring new methods to eradicate HIV that lingers in brain cells despite conventional antiviral treatment is the focus of a new study by investigators at Children’s Hospital and Temple University.
Australia’s 60 Minutes recently revisited its story from last year about the revolutionary immune therapy treatment spearheaded by The Children’s Hospital of Philadelphia’s Stephan A. Grupp, MD, PhD.
Kelly A. Dougherty, PhD recently received an award from the NIH that will support her investigation of vitamin A supplementation and sickle cell disease.
A Children’s Hospital of Philadelphia pediatrician’s research projects span across continents to Botswana, a sub-Saharan African country with a busy clinic for 2,000 HIV-infected children and adolescents who stole her heart.